Skip to main content
Clinical Trials/NL-OMON20951
NL-OMON20951
Not yet recruiting
Not Applicable

on-invasive imaging of Peripheral Vascular Disease with MultiSpectral Optoacoustic Tomography (PVD-MSOT), a Pilot Study.

niversity Medical Center Groningen (UMCG). http://www.umcg.nl0 sites24 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral vascular disease, MSOT, atherosclerosis, diabetes mellitus, Fontaine classification, duplex ultrasoundPerifeer vaatlijden, atherosclerose, Fontaine classificatie, echo duplex.
Sponsor
niversity Medical Center Groningen (UMCG). http://www.umcg.nl
Enrollment
24
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversity Medical Center Groningen (UMCG). http://www.umcg.nl

Eligibility Criteria

Inclusion Criteria

  • Patients attending the outpatient clinic of the vascular surgey at the Universal Medical Center Groningen.
  • \- Age \> 18 years.
  • \- Peripheral Vascular Disease Fontaine Classification stages II, III, or IV.
  • \- Obtained written informed consent.

Exclusion Criteria

  • \- Medical or psychiatric conditions that compromise the patient's ability to give informed consent.
  • \- Previous surgical or radiological treatment (percutaneous procedures with or without stenting) for PVD in the legs.
  • \- Surgical treatment for skin abnormalities (e.g. removal of skin, skin transplants and/or tattooing).
  • \- Active auto\-immune vascular diseases.
  • \- Lower leg fractures within the past 12 months.
  • \- Pregnancy or breast feeding.
  • \- (Partial) amputation of one of the legs and/or toes.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
on-invasive imaging of Peripheral Vascular Disease with MultiSpectral Optoacoustic Tomography (PVD-MSOT), a Pilot Study.peripheral vascular disease10003216
NL-OMON41212niversitair Medisch Centrum Groningen24
Completed
Not Applicable
Diagnostic Imaging for Peripheral Arterial Disease: the DIPAD trialPeripheral Arterial Disease (PAD)Circulatory System
ISRCTN26717851Erasmus Medical Centre (Netherlands)514
Unknown
Phase 3
Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease PatientsPeripheral Vascular Disease Patient
NCT02624674Unity Health Toronto20
Completed
Not Applicable
Diagnostic Imaging for Peripheral Arterial Disease: the DIPAD trial.Peripheral arterial disease (PAD) is the expression of atherosclerosis in the lower limb distal to the aortic bifurcation, which is a major problem in the population of 55 years and older. The first manifestation of symptomatic PAD is usually intermittent claudication. In a minority of patients, the disease progresses to critical limb ischemia, i.e. rest pain and tissue necrosis.PAD was defined as symptoms of intermittent claudication and/ or critical ischemia with an ankle-brachial index < 0.90.
NL-OMON26004-Prof. Dr. M.G.M. HuninkDept of Radiology and Dept of Epidemiology & Biostatistics, Program for the Assessment of Radiological Technology (ART), Erasmus Medical Center Rotterdam-Prof. Dr. J.M.A. van EngelshovenDept of RadiologyAcademic Hospital MaastrichtP.O. box 58006202 AZ Maastricht514
Completed
Not Applicable
Laser Speckle Imaging in Ischaemic Tissue LossVascular Diseases
NCT06011447The Leeds Teaching Hospitals NHS Trust8